Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma (vol 98, pg 464, 2023)

被引：0
|
作者：
Desai, S. H.
Spinner, M. A.
David, K.
机构：
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 11期
关键词：
D O I：
10.1002/ajh.27103
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1818 / 1818
页数：1
相关论文
共 23 条
  • [21] Pre-transplant FDG-PET scan response and other prognostic factors based survival model in patients with relapsed and refractory Hodgkin's lymphoma is useful to predict outcome after high dose chemotherapy and autologous stem cell transplant
    Akhtar, S.
    Al-Sugair, A.
    Abouzied, M.
    AlKadhi, Y.
    Abdelsalam, M.
    Dingle, M.
    Soudy, H.
    Darwish, A.
    Eltigani, A.
    Elhassan, T.
    Nabil-Ahmed, M.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S49 - S50
  • [22] Time-dependent effect of non-Hodgkin's lymphoma grade on disease free survival (DSF) of relapsed/refractory patients treated with high-dose chemotherapy (HDC) plus autologous hematopoietic stem cell transplant (AHSCT).
    Fu, PF
    Van Heeckeren, WJ
    Wadhwa, PD
    Bajor, DJ
    Creger, RJ
    Cooper, BW
    Laughlin, MJ
    Lazarus, HM
    Gerson, SL
    Koc, ON
    BLOOD, 2004, 104 (11) : 262A - 263A
  • [23] Augmented preparative regimens using total body irradiation or BCNU prior to autologous stem cell transplant (AuSCT) are well-tolerated and yield substantial rates of progression-free survival in patients with poor risk Hodgkin lymphoma (HL) or diffuse large B-cell lymphoma (DLBCL).
    Ritchie, DS
    Seymour, JF
    Thompson, S
    McManus, M
    Prince, M
    BLOOD, 2005, 106 (11) : 463B - 463B
123